Abstract
Multipurpose prevention technologies (MPTs) are pharmaceutical products being developed for multiple indications, primarily prevention of HIV, pregnancy, and/or sexually transmitted infections. MPT products could be a combination of multiple drugs co-formulated for separate indications, or a single product with multiple indications. This paper reviews MPT work published since 2013, including technical papers on aspects of product development, papers focused on issues that will be critical to future MPT clinical research and introduction, and selected papers concerning products for prevention of pregnancy or HIV/STIs. Collaborative efforts between researchers and funders aim to provide efficiencies in the product development process, building on experiences from both the contraceptive and vaginal microbicide fields.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
